ESC 365 - Polymorphisms of the ALOX5AP gene (5-lipoxygenase activating protein) are associated with increased cardiovascular risk in patients with acute coronary syndrome: Analysis of PLATO genetics sub-study.

ESC Premium Access

Polymorphisms of the ALOX5AP gene (5-lipoxygenase activating protein) are associated with increased cardiovascular risk in patients with acute coronary syndrome: Analysis of PLATO genetics sub-study.

Session: Best Posters 4 - Best Posters in genomics to therapy

Topic: Genetics and gene therapy

Speaker: Doctor C. Balendran (Gothenburg, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Clare Balendran

AstraZeneca, Gothenburg (Sweden)

0 follower

4 more presentations in this session

Discussant: Best Posters in genomics to therapy

Systematic analysis of cardiac disease genes in pediatric cardiomyopathy patients identifies novel genetic variants.

Speaker: Doctor J. Kuehnisch (Berlin, DE)

Investigating dilated cardiomyopathy caused by dystrophin mutations using duchenne muscular dystrophy-patients induced pluripotent stem cell-derived cardiomyocytes

Speaker: Mr B. Eisen (Haifa, IL)

The endocannabinoid system is a novel therapeutic target for muscular dystrophy cardiomyopathy.

Speaker: Doctor A. Gowran (Milan, IT)

Access the full session

Best Posters 4 - Best Posters in genomics to therapy

Speakers: Doctor C. Balendran, Doctor J. Kuehnisch, Mr B. Eisen, Doctor A. Gowran

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources